AU2001292898A1 - Substituted azepino[4,5b)indole derivatives - Google Patents

Substituted azepino[4,5b)indole derivatives

Info

Publication number: AU2001292898A1
Authority: AU; Australia
Prior art keywords: indole derivatives; azepino; substituted; substituted azepino; indole
Prior art date: 2000-09-20
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2001292898A

Other languages

English (en)

Inventor

Brad A. Acker

Michael D Ennis

Jed F. Fisher

Kristine E. Frank

Jian-Min Fu

Eric Jon Jacobsen

William W Mc Whorter

Jeanette K. Morris

Donald Joseph Rogier Jr.

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Pharmacia and Upjohn Co

Original Assignee

Pharmacia and Upjohn Co

Upjohn Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-09-20

Filing date

2001-09-20

Publication date

2002-04-02

2001-09-20 Application filed by Pharmacia and Upjohn Co, Upjohn Co filed Critical Pharmacia and Upjohn Co

2002-04-02 Publication of AU2001292898A1 publication Critical patent/AU2001292898A1/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurology (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Biomedical Technology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Psychology (AREA)
Child & Adolescent Psychology (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Hospice & Palliative Care (AREA)
Addiction (AREA)
Anesthesiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Indole Compounds (AREA)

AU2001292898A 2000-09-20 2001-09-20 Substituted azepino[4,5b)indole derivatives Abandoned AU2001292898A1 (en)

Applications Claiming Priority (7)

Application Number	Priority Date	Filing Date	Title
US23437600P	2000-09-20	2000-09-20
US60234376		2000-09-20
US26604701P	2001-02-01	2001-02-01
US60266047		2001-02-01
US30196401P	2001-06-29	2001-06-29
US60301964		2001-06-29
PCT/US2001/029535 WO2002024701A2 (en)	2000-09-20	2001-09-20	Substituted azepino[4,5b)indole derivatives

Publications (1)

Publication Number	Publication Date
AU2001292898A1 true AU2001292898A1 (en)	2002-04-02

Family

ID=27398561

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AU2001294606A Abandoned AU2001294606A1 (en)	2000-09-20	2001-09-20	Substituted azepino(4,5b)indoline derivatives
AU2001292898A Abandoned AU2001292898A1 (en)	2000-09-20	2001-09-20	Substituted azepino[4,5b)indole derivatives

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
AU2001294606A Abandoned AU2001294606A1 (en)	2000-09-20	2001-09-20	Substituted azepino(4,5b)indoline derivatives

Country Status (7)

Country	Link
US (4)	US6586421B2 (es)
EP (2)	EP1319004A2 (es)
JP (2)	JP2004509893A (es)
AR (2)	AR035493A1 (es)
AU (2)	AU2001294606A1 (es)
PE (2)	PE20020443A1 (es)
WO (2)	WO2002024700A2 (es)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1575984A4 (en) *	2001-02-16	2006-09-06	Bristol Myers Squibb Co	IDENTIFICATION AND CLONING OF A NEW HUMAN GENE, RET16, PLAYING A ROLE IN THE CASCADE INTRACELLULAR SIGNALING CASCADE
EP1281700A1 (en) *	2001-07-31	2003-02-05	Resolution Research Nederland B.V.	Manufacturing process for the preparation of alpha, alpha-branched alkane carboxylic acids providing esters with an improved softness
CA2453537A1 (en) *	2001-08-08	2003-02-20	Pharmacia & Upjohn Company	Therapeutic 1h-pyrido¬4,3-b\|indoles
TWI329111B (en) *	2002-05-24	2010-08-21	X Ceptor Therapeutics Inc	Azepinoindole and pyridoindole derivatives as pharmaceutical agents
US7595311B2 (en) *	2002-05-24	2009-09-29	Exelixis, Inc.	Azepinoindole derivatives as pharmaceutical agents
AU2002950217A0 (en)	2002-07-16	2002-09-12	Prana Biotechnology Limited	8- Hydroxy Quinoline Derivatives
US7592454B2 (en)	2004-04-14	2009-09-22	Bristol-Myers Squibb Company	Substituted hexahydro-pyridoindole derivatives as serotonin receptor agonists and antagonists
US7718647B2 (en) *	2004-06-30	2010-05-18	Athersys, Inc.	Substituted azepine derivatives as serotonin receptor modulators
EP1792629A4 (en)	2004-08-25	2010-08-25	Takeda Pharmaceutical	MEANS FOR THE PREVENTION / TREATMENT OF STRESS-RELATED HARNINE INCONTINENCE AND PRECAUTIONARY METHOD FOR THIS
EP1747779A1 (en) *	2005-07-28	2007-01-31	Laboratorios Del Dr. Esteve, S.A.	Tetrahydro-b-carbolin-sulfonamide derivatives as 5-HT6 ligands
MX2008009178A (es) *	2006-01-19	2008-12-05	Athersys Inc	Tiofenil y pirrolil acepinas como ligandos del receptor de serotonina 5-ht2c y sus usos.
EP2727585A1 (en)	2006-05-16	2014-05-07	Takeda Pharmaceutical Company Limited	In-vivo screening method
WO2009035574A1 (en) *	2007-09-10	2009-03-19	Merck & Co., Inc.	Method for measuring mitochondrial membrane potential in vertebrate cells
US7816435B2 (en) *	2007-10-31	2010-10-19	Momentive Performance Materials Inc.	Halo-functional silane, process for its preparation, rubber composition containing same and articles manufactured therefrom
US20100266504A1 (en)	2007-11-15	2010-10-21	Takahiro Matsumoto	Condensed pyridine derivative and use thereof
ES2523580T3 (es)	2008-01-11	2014-11-27	Albany Molecular Research, Inc.	Piridoindoles substituidos con (1-Azinona)
US9625475B2 (en)	2008-09-29	2017-04-18	Abbvie Inc.	Indole and indoline derivatives and methods of use thereof
US9063126B2 (en)	2008-09-29	2015-06-23	Abbvie Inc.	Indole and indoline derivatives and methods of use thereof
AU2009308706C1 (en) *	2008-10-31	2016-01-21	Medivation Technologies, Inc.	Pyrido (4,3-b) indoles containing rigid moieties
AR073924A1 (es) *	2008-10-31	2010-12-09	Medivation Technologies Inc	Azepino[4, 5-b]indoles, una composicion farmaceutica y kits que los comprenden y su uso en la modulacion de un receptor de histamina.
US8618299B2 (en)	2009-07-01	2013-12-31	Albany Molecular Research, Inc.	Azinone-substituted azapolycycle MCH-1 antagonists, methods of making, and use thereof
JP2012532144A (ja) *	2009-07-01	2012-12-13	アルバニーモレキュラーリサーチ，インコーポレイテッド	アジノン置換アゼピノ［ｂ］インドールおよびピリド−ピロロ−アゼピンｍｃｈ−１拮抗薬、ならびにその作製方法および使用
US9073925B2 (en)	2009-07-01	2015-07-07	Albany Molecular Research, Inc.	Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof
WO2011003007A1 (en)	2009-07-01	2011-01-06	Albany Molecular Research, Inc.	Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof
US20120253036A1 (en)	2009-12-11	2012-10-04	Yukinori Nagakura	Agent for treating fibromyalgia
WO2011103433A1 (en) *	2010-02-18	2011-08-25	Medivation Technologies, Inc.	Pyrido[4,3-b]indole and pyrido[3,4-b]indole derivatives and methods of use
WO2011103487A1 (en) *	2010-02-18	2011-08-25	Medivation Technologies, Inc.	Pyrido[4,3-b]indole and pyrido[3,4-b]indole derivatives and methods of use
US9193728B2 (en)	2010-02-18	2015-11-24	Medivation Technologies, Inc.	Fused tetracyclic pyrido [4,3-B] indole and pyrido [3,4-B] indole derivatives and methods of use
WO2011103485A1 (en)	2010-02-18	2011-08-25	Medivation Technologies, Inc.	Fused tetracyclic pyrido[4,3-b]indole and pyrido[3,4-b]indole derivatives and methods of use
WO2011103430A1 (en) *	2010-02-19	2011-08-25	Medivation Technologies, Inc.	Pyrido[4,3-b]indole and pyrido[3,4-b]indole derivatives and methods of use
US8697700B2 (en)	2010-12-21	2014-04-15	Albany Molecular Research, Inc.	Piperazinone-substituted tetrahydro-carboline MCH-1 antagonists, methods of making, and uses thereof
US8993765B2 (en)	2010-12-21	2015-03-31	Albany Molecular Research, Inc.	Tetrahydro-azacarboline MCH-1 antagonists, methods of making, and uses thereof
WO2012112965A1 (en) *	2011-02-18	2012-08-23	Medivation Technologies, Inc.	Compounds and methods of treating diabetes
US8815843B2 (en) *	2011-02-18	2014-08-26	Medivation Technologies, Inc.	Compounds and methods of treating diabetes
WO2012112963A1 (en)	2011-02-18	2012-08-23	Medivation Technologies, Inc.	Compounds and methods for treatment of hypertension
US20130178618A1 (en) *	2012-01-10	2013-07-11	William Allen Boulanger	Novel pharmaceutical intermediates and methods for preparing the same
US20150315188A1 (en) *	2012-08-22	2015-11-05	Medivation Technologies, Inc.	Compounds and methods for treatment of hypertension
US12343337B2 (en)	2016-09-29	2025-07-01	The Regents Of The University Of California	Compounds for increasing neural plasticity
EP3525763B1 (en)	2016-10-12	2025-03-05	Intra-Cellular Therapies, Inc.	Amorphous solid dispersions
CN116327770B (zh)	2017-03-24	2025-10-31	细胞内治疗公司	新组合物和方法
US20210052600A1 (en)	2017-12-27	2021-02-25	Takeda Pharmaceutical Company Limited	Therapeutic agents for stress urinary incontinence and incotinence of feces
EP3843729A4 (en)	2018-08-29	2022-06-01	Intra-Cellular Therapies, Inc.	NEW COMPOSITIONS AND METHODS
US10695345B2 (en)	2018-08-31	2020-06-30	Intra-Cellular Therapies, Inc.	Pharmaceutical capsule compositions comprising lumateperone mono-tosylate
EP3843738A4 (en)	2018-08-31	2022-06-01	Intra-Cellular Therapies, Inc.	NEW METHODS
JP7636796B2 (ja)	2019-02-27	2025-02-27	ザリージェンツオブザユニバーシティオブカリフォルニア	脳障害を治療するためのｎ－置換インドール及び他の複素環化合物
EP3931189B1 (en)	2019-02-27	2025-12-24	The Regents Of The University Of California	Azepino-indoles and other heterocycles for treating brain disorders
CN111053789A (zh) *	2019-11-26	2020-04-24	湖南营养树生物科技有限公司	调节免疫系统的方法和组合物
US20230257385A1 (en)	2021-11-17	2023-08-17	Terran Biosciences Inc.	Salt and solid forms of tabernanthalog
WO2023114313A1 (en) *	2021-12-15	2023-06-22	Delix Therapeutics, Inc.	Phenoxy and benzyloxy substituted psychoplastogens and uses thereof
AU2022415426A1 (en) *	2021-12-15	2024-07-25	Delix Therapeutics, Inc.	Fused pyrrolidine psychoplastogens and uses thereof
WO2023122135A1 (en) *	2021-12-22	2023-06-29	Kuleon Llc	Serotonin receptor agonists and methods of making and using the same
WO2023212811A1 (en) *	2022-05-06	2023-11-09	Bright Minds Biosciences Inc.	Azepinoindoles and methods of preparation thereof
US12116372B1 (en)	2023-12-14	2024-10-15	William Allen Boulanger	Process for preparing methyl 3-bromo-2-(2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl)propanoate
CN120607526A (zh) *	2024-05-31	2025-09-09	和径医药科技（上海）有限公司	三并环类化合物、其药物组合物及应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR6699E (fr)	1905-09-25	1907-01-31	Maurice Honore Firmin Muraire	Machine à enfiler les cocons de vers à soie
DE1062840B (de)	1953-03-03	1959-08-06	Siemens Reiniger Werke Ag	Eirichtung zur Sichtbarmachung usichtbarer, bzw. zur Verstaerkung sichtbarer,durch Korpuskular- oder Wellenstrahlung hervorgerufener Bilder, insbesondere fuer Roentgendurchleuchtungen
CH445512A (de) *	1964-12-03	1967-10-31	Geigy Ag J R	Verfahren zur Herstellung von neuen Indolderivaten
US3839357A (en)	1966-05-10	1974-10-01	Upjohn Co	1,2,3,4,5,6-hexahydroazepino(4,5-b)indoles
GR35044B (el)	1966-05-10	1968-07-31	The Upjohn Company	Μεθοδος παρασκευης οργανικων ενωσεων.
US3525750A (en)	1966-05-31	1970-08-25	Geigy Chem Corp	1,2,3,4,5,6-hexahydro-azepino(4,5-b) indole derivatives
US3553232A (en)	1967-08-25	1971-01-05	Upjohn Co	4-(1,4,5,6-tetrahydroazepine(4,5-b)indole-3(2h)-yl)butyrophenones
US3622673A (en)	1968-11-14	1971-11-23	Upjohn Co	4-(1,4,5,6-TETRAHYDROZEPINO 4,5-b INDOL-3(2H)-YL-BUTYROPHENON COMPOSITIONS AND PROCESS OF TREATMENT MENTAL OR EMOTIONAL DISORDERS
US3652588A (en)	1969-10-23	1972-03-28	Upjohn Co	6-alkyl-1 2 3 4 5 6-hexahydroazepino(4 5-b)indoles
US3676558A (en)	1970-08-28	1972-07-11	Upjohn Co	Anorexigenic compositions comprising 6-alkyl-1,2,3,4,5,6-hexahydroazepino 4,5-indoles as active ingredient and process of treatment
US3776922A (en)	1972-03-24	1973-12-04	J Epstein	Indole carboxaldehydes
ATE12641T1 (de)	1979-11-02	1985-04-15	Sandoz Ag	Azepinindole, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
CH649553A5 (de) *	1982-05-06	1985-05-31	Sandoz Ag	Azepinoindole und verfahren zu deren herstellung.
JPS63163347A (ja)	1986-12-25	1988-07-06	Konica Corp	有機着色物質の光褪色防止方法
EP0377238A1 (en)	1988-12-22	1990-07-11	Duphar International Research B.V	New annelated indolo (3,2-c)-lactams
FR2663935A1 (fr) *	1990-06-27	1992-01-03	Adir	Nouveaux 1,2,3,4,5,6-hexahydroazepino [4,5-b] indoles et 1,2,3,4-tetrahydrobethacarbolines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
PE20010052A1 (es)	1999-04-23	2001-01-27	Upjohn Co	Compuestos de azepinindol tetraciclico como agonistas o antagonistas del receptor de 5-ht
AR024378A1 (es)	1999-06-15	2002-10-02	Du Pont Pharm Co	Gamma-carbolinas fusionadas heterociclicas sustituidas
DE19929076A1 (de)	1999-06-25	2000-12-28	Aventis Pharma Gmbh	Indanylsubstituierte Benzolcarbonamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
MY122278A (en)	1999-07-19	2006-04-29	Upjohn Co	1,2,3,4,5,6-hexahydroazepino[4,5-b]indoles containing arylsulfones at the 9-position
WO2002004456A1 (en) *	2000-07-06	2002-01-17	Pharmacia & Upjohn Company	SUBSTITUTED 2,3,7,8,9,10,11,12-OCTAHYDROAZEPINO[4,5-b]PYRANO[3,2-e]INDOLES

2001
- 2001-09-20 EP EP01973304A patent/EP1319004A2/en not_active Withdrawn
- 2001-09-20 AR ARP010104449A patent/AR035493A1/es not_active Application Discontinuation
- 2001-09-20 US US09/957,319 patent/US6586421B2/en not_active Expired - Fee Related
- 2001-09-20 WO PCT/US2001/029447 patent/WO2002024700A2/en not_active Ceased
- 2001-09-20 AR ARP010104450A patent/AR034264A1/es unknown
- 2001-09-20 AU AU2001294606A patent/AU2001294606A1/en not_active Abandoned
- 2001-09-20 JP JP2002529110A patent/JP2004509893A/ja active Pending
- 2001-09-20 JP JP2002529111A patent/JP2004509894A/ja not_active Withdrawn
- 2001-09-20 EP EP01975267A patent/EP1319005A2/en not_active Withdrawn
- 2001-09-20 AU AU2001292898A patent/AU2001292898A1/en not_active Abandoned
- 2001-09-20 US US09/957,625 patent/US6583135B2/en not_active Expired - Fee Related
- 2001-09-20 PE PE2001000945A patent/PE20020443A1/es not_active Application Discontinuation
- 2001-09-20 PE PE2001000944A patent/PE20020510A1/es not_active Application Discontinuation
- 2001-09-20 WO PCT/US2001/029535 patent/WO2002024701A2/en not_active Ceased
2003
- 2003-03-20 US US10/393,968 patent/US6903090B2/en not_active Expired - Fee Related
- 2003-03-20 US US10/394,676 patent/US6828314B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US20020077318A1 (en)	2002-06-20
PE20020510A1 (es)	2002-06-12
EP1319005A2 (en)	2003-06-18
PE20020443A1 (es)	2002-05-16
US6583135B2 (en)	2003-06-24
US6903090B2 (en)	2005-06-07
US6586421B2 (en)	2003-07-01
EP1319004A2 (en)	2003-06-18
US20030220321A1 (en)	2003-11-27
JP2004509894A (ja)	2004-04-02
WO2002024700A2 (en)	2002-03-28
JP2004509893A (ja)	2004-04-02
AU2001294606A1 (en)	2002-04-02
WO2002024700A3 (en)	2002-06-13
AR034264A1 (es)	2004-02-18
US20030225058A1 (en)	2003-12-04
AR035493A1 (es)	2004-06-02
US6828314B2 (en)	2004-12-07
WO2002024701A2 (en)	2002-03-28
WO2002024701A3 (en)	2002-06-13
US20020107278A1 (en)	2002-08-08

Publication	Publication Date	Title
AU2001292898A1 (en)	2002-04-02	Substituted azepino[4,5b)indole derivatives
AU2001230026A1 (en)	2001-08-14	2,4-diaminothiazole derivatives
AU2002227170A1 (en)	2002-05-15	Cycloalkyl(b)(1,4)diazepino(6,7,1-hi)indoles and derivatives
AU2002361992A1 (en)	2003-07-09	1,4-dihydro-1,4-diphenylpyridine derivatives
AU2001280099A1 (en)	2002-04-02	4-acylaminopyrazole derivatives
AU2001230584A1 (en)	2001-08-20	1h-imidazopyridine derivatives
AU2001230537A1 (en)	2001-08-14	Pyridoxazine derivatives
AU2001231664A1 (en)	2001-11-01	Indol-3-yl derivatives
AU2001281802A1 (en)	2001-12-17	6-phenylpyrrolopyrimidinedione derivatives
AU2001278790A1 (en)	2002-03-04	1h-imidazopyridine derivatives
AU2002213978A1 (en)	2002-06-27	Substituted C-cyclohexylmethylamine derivatives
AU3819200A (en)	2000-11-02	2,4-diamino-pyrimidine derivatives
AU2002212301A1 (en)	2002-04-15	Diazacycloalkanedione derivatives
AU2610299A (en)	1999-08-23	Hydrazone derivatives
ZA200207341B (en)	2004-01-21	Novel 2,3,4,5-tetrahydro-1H-[1,4]diazepino[1,7a]indole compounds.
AU2002212959A1 (en)	2002-04-29	Cycloalkylfluorosulfonamide derivatives
AU2001254661A1 (en)	2001-09-03	Aminosulfonylbiphenyl derivatives
AU2002215212A1 (en)	2002-08-01	1-methylcarbapenem derivatives
AU2001289937A1 (en)	2002-06-27	Substituted 1-aminobutan-3-ol derivatives
AU2001230565A1 (en)	2001-08-14	Perfluoroisopropylbenzene derivatives
AU3667699A (en)	1999-11-16	Indolyl derivatives as serotonergic agents
AU2002218400A1 (en)	2002-06-03	3-substituted 2,7-naphthyridin-1-yl derivatives
AU2001242772A1 (en)	2001-10-03	3-substituted-4-pyrimidone derivatives
AU2709001A (en)	2001-08-07	Substituted tryptophan derivatives
AU3967099A (en)	1999-11-16	Indolyl derivatives as serotonergic agents